Pellsys Pharma Private Limited, a active private limited company, was established on 19 December 2008 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233TG2008PTC062293. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.32 Cr and a paid-up capital of ₹2.32 Cr.
It upholds a compliant status. Employing 14 professional, Its leadership includes Venugopal Setty Sarvisetty (Director), Cherupalli Ganesh (Whole-Time Director), Ramesh Babu Sarvisetty (Whole-Time Director). Past directors included Venkateswara Rao Chitturi, Kishore Kumar Gattam, Venugopal Setty Sarvisetty. It holds ₹2.50 Cr open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 73, Road No 03, I.D.A. Cherlapally, Phase-1, Hyderabad, Telangana, 500051.
U24233TG2008PTC062293
062293
19 December 2008
₹2.32 Cr
₹2.32 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Pellsys Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venugopal Setty Sarvisetty | Director | 09 Jul 2013 | Current |
| Cherupalli Ganesh | Whole-Time Director | 19 Dec 2008 | Current |
| Ramesh Babu Sarvisetty | Whole-Time Director | 09 Jul 2013 | Current |
| Srinulakshmi Perumallu Chaladi | Managing Director | 19 Dec 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jul 2013 | Past |
| Pramod Abcsdd | Director | 09 Jul 2013 | Past |
| Pramod Abcsdd | Additional Director | 09 Jul 2013 | Past |
| Pramod Abcsdd | Director | 19 Dec 2008 | Past |
| Pramod Abcsdd | Additional Director | 09 Jul 2013 | Past |
| Pramod Abcsdd | Director | 19 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pellsys Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.84% increase. The company also saw a substantial improvement in profitability, with a 101.41% increase in profit. The company's net worth Soared by an impressive increase of 16.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pellsys Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹25,000,000.00
₹30,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2014 | Hdfc Bank Limited | ₹2.50 Cr | Open |
| 07 Sep 2009 | State Bank Of Patiala | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Pellsys Pharma has a workforce of 14 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pellsys Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pellsys Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pellsys Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Pellsys Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Hdfc Bank Limited of Rs. 2.50 Cr registered on 26 Aug 2014 with Charge ID 10520082 was modified on 22 Feb 2022. was recorded as a recent event.
A charge registered on 07 Sep 2009 via Charge ID 10179461 with State Bank Of Patiala was fully satisfied on 27 Oct 2014. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 2.50 Cr with Charge ID 10520082 was registered on 26 Aug 2014. was recorded as a recent event.
The activity Venugopal Setty Sarvisetty was appointed as a Director was appointed as a Director on 09 Jul 2013 & has been associated with this company since 12 years 4 months . was completed.
The CIN of Pellsys Pharma Private Limited is U24233TG2008PTC062293.
Pellsys Pharma Private Limited is headquartered at Plot No. 73, Road No 03, I.D.A. Cherlapally, Phase-1, Hyderabad, Telangana, 500051.
Pellsys Pharma Private Limited was incorporated on 19 December 2008.
The current directors of Pellsys Pharma Private Limited are
The primary industry of Pellsys Pharma Private Limited is Manufacturing.
Pellsys Pharma Private Limited is unlisted.
The authorized capital of Pellsys Pharma Private Limited is ₹2.32 Cr, and the paid-up capital is ₹2.32 Cr.
The compliance status of Pellsys Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX